Prof. Sir John Irving Bell
Personal Data
Nationality: Canadian (UK Permanent Resident)
Year of Birth: July 1, 1952
Studies
- 1966 - 1971:
Ridley College, Canada - 1975:
B Med Sci (Honours). University of Alberta - 1976:
BA (Honours), Physiological Sciences, 1st Class, Magdalen College, Oxford University - 1979:
BM, BCh. Magdalen College, Oxford University - 1990:
DM Magdalen College, Oxford University - 1992:
FRCP Royal College of Physicians, London
Posts previously held
- 1979 - 1982:
Postgraduate Clinical Training in Oxford and London - 1982 - 1987:
Clinical Fellow, Department of Medicine, Stanford University, Stanford, California, USA - 1982 - 1987:
Postdoctoral Fellow, Department of Medical Microbiology, Stanford University, Stanford, California, USA - 1987 - 1989:
Wellcome Senior Clinical Fellow and Honorary Consultant
Physician, Nuffield Departments of Clinical Medicine and Surgery, John Radcliffe Hospital, Oxford - 1989 - 1992:
University Lecturer, Nuffield Department of Clinical Medicine, Oxford University - 1992 - 2002:
Nuffield Professor of Clinical Medicine, Oxford University - since 2002:
Regius Professor of Medicine, Oxford University - 2006 - 2011:
President, Academy of Medical Sciences, UK
University post currently held
- since 1987:
Hon. Consultant Physician, Oxford Radcliffe NHS Trust - since 1992:
Nuffield Professor of Clinical Medicine
Chairman, Department of Medicine, Oxford University School of Medicine - since 1993:
Founder, Wellcome Trust Centre for Human Genetics - since 1999:
Chairman, Partnership Board, Oxford Centre for Diabetes, Endocrinology and Metabolism - since 1999:
Chairman, Trials and Epidemiology Building, Oxford - since 2002:
Regius Professor of Medicine - since 2008:
Knighted in the 2008 Honours list for Services to Medicine - since 2009:
Fellow of the Royal Society
Other activities/memberships
- Oxford University Hospitals Trust, Non-Executive Director
- Gray Laboratory Cancer Research Trust, Non-Executive Director
- The Edward Jenner Institute for Vaccine Research, Non-Executive Director
- Isis Innovation Limited, Non-Executive Director
- Genentech, Non-Executive Director
- Oxagen Ltd (biotech), Non-Executive Director
- 459-Plus (biotech), Non-Executive Director
- Oxford Health Alliance, Chairman
- GMEC, Chairman
- Office for the Strategic Coordination of Health Research, Chairman
- Human Genome Strategy Group, Chairman
- Advent Venture Partners, Advisor
- Hakluyt & Co, Advisor
- Bill and Melinda Gates Foundation, Advisor
- Robertson Foundation, Advisor
- Rhodes Trust, Trustee
- Ewelme Almshouse Charity, Master/Trustee
- Oxford Lotus Fund, Trustee